Medicare spends almost as much money screening for breast cancer as it does treating it, according to a new study published in JAMA Internal Medicine.
Breast cancer screenings cost Medicare $1.08 billion annually, lead researcher Dr. Cary Gross and his team at the Yale School of Medicine found. Given that Medicare spends $1.36 billion a year on breast cancer treatment, Gross said he expected the screenings costs to be much lower.
"It should be a call to do further research to identify the best...
Full Story